Table 1.
Summary of study demographic data for living donor and deceased donor kidney transplants using rapid discontinuation of prednisone for maintenance immunosuppression
| LD | DD | |
|---|---|---|
| Total transplants (n, % of total) | 791 (64) | 450 (36) |
| LRD | 456 (37) | |
| LURD | 335 (27) | |
| Median follow-up in months (IQR) | 63 (28–92) | 36 (19–75) |
| Recipient demographics | ||
| age | ||
| median age in years (IQR) | 48 (39–57) | 55 (46–63) |
| gender (n, % DD/LD) | ||
| male | 488 (62) | 266 (59) |
| race (n, % DD/LD) | ||
| Caucasian | 714 (90) | 337 (75) |
| African-American | 32 (4) | 38 (8) |
| primary renal disease (n, % DD/LD) | ||
| type 1 diabetes | 211 (27) | 97 (22) |
| type 2 diabetes | 90 (11) | 88 (20) |
| hypertensive nephropathy | 58 (7) | 44 (10) |
| IgA nephropathy | 62 (8) | 23 (5) |
| Peak PRA level (n, % DD/LD) | ||
| 0 | 473 (60) | 199 (44) |
| 1–10 | 196 (25) | 122 (27) |
| 11–50 | 75 (9) | 67 (15) |
| 51–100 | 45 (6) | 60 (13) |
| pretransplant type 1 diabetes (n, % DD/LD) | 214 (27) | 99 (22) |
| Donor demographics | ||
| age | ||
| median age in years (IQR) | 44 (35–50) | 41 (22–53) |
| sex (n, % DD/LD) | ||
| male | 312 (39) | 263 (58) |
| race (n, % DD/LD) | ||
| Caucasian | 723 (92) | 413 (92) |
| African American | 32 (4) | 19 (4) |
LD, living donor; DD, deceased donor; LRD, living related donor; LURD, living unrelated donor; IQR, interquartile range; PRA, panel reactive antibody.